Pip Marks
Impact in
- Hepatology top 5%
- Hepatitis C virus research
- Hepatitis Viruses Studies and Epidemiology
- Epidemiology top 10%
- Hepatitis B Virus Studies
- Liver Disease Diagnosis and Treatment
- HIV, Drug Use, Sexual Risk
Papers in
- Hepatology 14
- Hepatitis C virus research 14
- Epidemiology 11
- Hepatitis B Virus Studies 9
- Liver Disease Diagnosis and Treatment 5
- HIV, Drug Use, Sexual Risk 1
- Co-authors
- Gregory J. Dore (12 shared papers)Sharon R. Lewin (6 shared papers)Gail Matthews (9 shared papers)Stephen Locarnini (5 shared papers)Scott Bowden (4 shared papers)Joe Sasadeusz (4 shared papers)Anchalee Avihingsanon (5 shared papers)Kiat Ruxrungtham (5 shared papers)
- Journals
- Journal of Hepatology (4 papers)Hepatology (2 papers)Journal of Clinical Virology (1 paper)Antiviral Therapy (1 paper)AIDS (1 paper)
- Partner nations
- AustraliaThailandUnited States
In The Last Decade
Pip Marks
13 papers receiving 279 citations
Peers
Comparison fields: 5 of 30
- Hepatology 249
- Epidemiology 273
- Virology 26
- Infectious Diseases 91
- Emergency Medicine 10
Countries citing papers authored by Pip Marks
This map shows the geographic impact of Pip Marks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pip Marks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pip Marks more than expected).
Fields of papers citing papers by Pip Marks
This network shows the impact of papers produced by Pip Marks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pip Marks. The network helps show where Pip Marks may publish in the future.
Co-authors
The 25 scholars most cited alongside Pip Marks, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 102 | |
| 2 | 2009 | 42 | |
| 3 | 2009 | 35 | |
| 4 | 2012 | 25 | |
| 5 | 2017 | 24 | |
| 6 | 2003 | 21 | |
| 7 | 2008 | 18 | |
| 8 | 2014 | 12 | |
| 9 | 2013 | 4 | |
| 10 | 2019 | 3 | |
| 11 | 2020 | 2 | |
| 12 | 2019 | 2 | |
| 13 | 2019 | 1 | |
| 14 | 2020 | 0 |
About Pip Marks
Pip Marks is a scholar working on Hepatology, Epidemiology, Infectious Diseases, Virology and Rheumatology, having authored 14 papers that have together received 291 indexed citations. Recurring topics across this work include Hepatitis C virus research (14 papers), Hepatitis B Virus Studies (9 papers), Liver Disease Diagnosis and Treatment (5 papers), HIV/AIDS drug development and treatment (3 papers), HIV Research and Treatment (2 papers), HIV, Drug Use, Sexual Risk (1 paper), HIV-related health complications and treatments (1 paper) and HIV/AIDS Research and Interventions (1 paper). The work is most often cited by research in Hepatology (249 citations), Epidemiology (273 citations), Virology (26 citations), Infectious Diseases (91 citations) and Emergency Medicine (10 citations). Pip Marks has collaborated with scholars based in Australia, Thailand and United States. Frequent co-authors include Gregory J. Dore, Sharon R. Lewin, Gail Matthews, Stephen Locarnini, Scott Bowden, Joe Sasadeusz, Anchalee Avihingsanon, Kiat Ruxrungtham, David A. Cooper and Rungsun Rerknimitr. Their work appears in journals such as Journal of Hepatology, Hepatology, Journal of Clinical Virology, Antiviral Therapy and AIDS.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.